Lesaka Technologies, Inc. filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission on September 9, 2026, covering the fiscal year ended June 30, 2026.
Lesaka Technologies, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on September 9, 2026, disclosing a press release covering its financial results for the fourth quarter and fiscal year ended June 30, 2026.
Brandon Sim, CEO and President of Astrana Health, Inc. (NASDAQ:ASTH), filed a Form 4 on September 9, 2026, reporting a disposition of common stock on September 5, 2026, related to the vesting of restricted stock units.
Martine A. Rothblatt, Chairperson and CEO of United Therapeutics Corporation, filed a Form 4 on September 9, 2026, disclosing the exercise of 9,500 stock options and the sale of 9,260 shares of common stock on September 8, 2026, pursuant to a pre-arranged Rule 10b5-1 …
Andrew Cappotelli, Senior Vice President of Operations at Paylocity Holding Corp, filed a Form 4 on September 9, 2026, reporting a sale of common stock that occurred on September 4, 2026.
Bradley T. Wiemann, Executive Vice President of Daktronics Inc /SD/, filed a Form 4 on September 9, 2026, disclosing the accelerated vesting of restricted stock units on September 5, 2026, his designated retirement date.
Kumar Budur, Chief Medical Officer of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY), filed a Form 4 on September 9, 2026, disclosing a series of open-market sales and stock option exercises in common stock between September 4 and September 8, 2026.
A Form 4 filed on September 9, 2026 disclosed that Fred Aslan, Chief Executive Officer and Director of Artiva Biotherapeutics, Inc. (NASDAQ:ARTV), sold 23,429 shares of common stock on September 8, 2026 under a pre-established Rule 10b5-1 trading plan.
Danny Dumas, Senior Vice President of NA Sales, Marketing and Product Management at Del Monte Corp, filed a Form 4 on September 9, 2026, disclosing transactions in ordinary shares dated September 6 and September 8, 2026.
Keith D. Larson, General Counsel and Secretary of Venture Global, Inc. (NYSE:VG), filed a Form 4 on September 9, 2026, disclosing the exercise of stock options and subsequent sale of 2,350,000 shares of Class A Common Stock across two trading days.